Nature Medicine

Computable longitudinal patient journeys from structured and unstructured EHR data

By Edward Kim, Richard Foty, Avnesh S. Thakor, Vicki Seyfert-Margolis

Figure 1 from Nature Medicine — Figure 1. Kim et al.

Cohort study in peopleAI & data

Declared ties to: American Lung Association, Sanofi, Mount Sinai and 44 more

The paper

Edward Kim, Richard Foty, Avnesh S. Thakor, Vicki Seyfert-Margolis

Drexel University; RespondHealth

Nature Medicine, 10 Sep 2026

doi.org/10.1038/s41591-026-04695-x PubMed 42742184

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes